⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
MRK News
Merck & Co., Inc.
TailorMed and RxSense Partner to Surface Manufacturer Copay Assistance Within Digital Pharmacy Marketplaces
accessnewswire.com
BMY
SNY
MRK
LLY
Form 8-K
sec.gov
MRK
Merck & Co., Inc., Rahway, N.J., USA Announces Second-Quarter 2026 Financial Results; Highlights Key Regulatory and Clinical Milestones Across Broad, Diverse Pipeline
businesswire.com
MRK
Evexta Bio gibt eine Kooperations- und Liefervereinbarung mit Roche zur klinischen Prüfung von Rupitasertib in Kombination mit einem selektiven Östrogenrezeptor-Degrader bei fortgeschrittenem bzw. metastasiertem Brustkrebs bekannt
businesswire.com
MRK
From Bench to Breakthrough: Empowering the Next Generation of Science Communicators
accessnewswire.com
MRK
Evexta Bio annonce une collaboration clinique et un contrat d'approvisionnement avec Roche afin d'évaluer le rupitasertib en association avec un dégradateur sélectif des récepteurs des œstrogènes dans le cancer du sein avancé ou métastatique
businesswire.com
MRK
Single-use Technologies for Biopharmaceuticals Market to Reach $16.31 Billion by 2031, Driven by Growing Monoclonal Antibody Production
globenewswire.com
TMO
MRK
Peripheral Artery Disease Clinical Trial Pipeline Expands as 17+ Companies Race to Redefine Peripheral Artery Disease Treatment Landscape | DelveInsight
globenewswire.com
CLRS
MDT
PHG
BSX
BDX
BIOT
ABT
ANGI
RMAX
MRK
SNY
JNJ
BA
GSK
AZN
PFE
NVO
AMGN
VRTX
Lupin Announces U.S. FDA Approval and Launch of Sugammadex Injection
prnewswire.com
MRK
Inflammatory Bowel Disease Market to Experience Strong Uptake During the Forecast Period (2026-2036), Driven by Development of Next-generation Therapies Targeting IL-23, TL1A, and S1P Pathways | DelveInsight
prnewswire.com
JNJ
MRK
TEVA
LLY
ABBV
PFE
AZN